ArticleScientific reports2026
Green synthesis of copper oxide nanoparticles with Calendula officinalis plant extract and investigation of its toxicity.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, copper oxide nanoparticles (CuO-NPs) were synthesized using a green, eco-friendly method employing the ethanolic extract of Calendula officinalis. The synthesis leveraged the plant's rich phytochemical profile to act as both reducing and capping agents, resulting in nanoparticles with enhanced biocompatibility and stability. The CuO-NPs were characterized using UV-Vis spectroscopy, FT-IR, X-ray diffraction (XRD), dynamic light scattering (DLS), and Atomic Force Microscopy (AFM), confirming their formation, functional groups, crystalline structure, and nanoscale dimensions. The average particle size was ~ 6.66 nm, with a negative zeta potential indicating good colloidal stability. Hemocompatibility and cytotoxicity were evaluated via hemolysis and MTT assays on normal HFF-2 human fibroblast cells. Results showed less than 5% hemolysis and relatively low cytotoxicity compared to chemically synthesized counterparts, highlighting the safety of the green synthesis method. This study demonstrates the potential of-mediated CuO-NPs as promising candidates for biomedical applications Calendula officinalis such as drug delivery and cancer therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.